Literature DB >> 21523033

(2E)-3-(3-Bromo-4-meth-oxy-phen-yl)-1-(pyridin-2-yl)prop-2-en-1-one.

Jerry P Jasinski, Ray J Butcher, S Samshuddin, B Narayana, H S Yathirajan.   

Abstract

The mean planes of the benzene and pyridine rings in the title compound, C(15)H(12)BrNO(2), are nearly coplanar, subtending an angle of 2.8 (8)°. The prop-2-en-1-one group is also in the plane of these rings with an N-C-C-O torsion angle of 179.6 (3)°. A weak C-H⋯Br inter-molecular inter-action contributes to the crystal packing, creating a chain-like structure along the a axis.

Entities:  

Year:  2011        PMID: 21523033      PMCID: PMC3051466          DOI: 10.1107/S1600536811000353

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For the pharmacological activity of chalcones, see: Dhar (1981 ▶); Dimmock et al. (1999 ▶); Satyanarayana et al. (2004 ▶). For their ability to block voltage-dependent potassium channels, see: Yarishkin et al. (2008 ▶). For their applications as organic non-linear optical materials due to their SHG conversion efficiency, see: Sarojini et al. (2006 ▶) and excellent blue light transmittance and good crystallization ability, see: Goto et al. (1991 ▶); Indira et al. (2002 ▶); Uchida et al. (1998 ▶). For the use of chalcones in the synthesis of various biodynamic heterocyclic compounds such as cyclo­hexenone and pyrazoline derivatives, see: Ashalatha et al. (2009 ▶); Sreevidya et al. (2010 ▶); Samshuddin et al. (2010 ▶); Fun et al. (2010a ▶,b ▶); Jasinski et al. (2010a ▶,b ▶). For the potential use of these compounds or chalcone-rich plant extracts as drugs or food preservatives, see: Di Carlo et al. (1999 ▶). For related structures, see: Bibila Mayaya Bisseyou et al. (2007 ▶); Liu et al. (2005 ▶).

Experimental

Crystal data

C15H12BrNO2 M = 318.17 Monoclinic, a = 26.3402 (13) Å b = 3.8906 (2) Å c = 27.5826 (17) Å β = 113.892 (5)° V = 2584.4 (2) Å3 Z = 8 Cu Kα radiation μ = 4.31 mm−1 T = 123 K 0.49 × 0.21 × 0.16 mm

Data collection

Oxford Diffraction Xcalibur Ruby Gemini diffractometer Absorption correction: multi-scan (CrysAlis RED; Oxford Diffraction, 2007 ▶) T min = 0.535, T max = 1.000 3978 measured reflections 2556 independent reflections 2431 reflections with I > 2σ(I) R int = 0.014

Refinement

R[F 2 > 2σ(F 2)] = 0.040 wR(F 2) = 0.115 S = 1.08 2556 reflections 173 parameters H-atom parameters constrained Δρmax = 0.85 e Å−3 Δρmin = −0.64 e Å−3 Data collection: CrysAlis PRO (Oxford Diffraction, 2007 ▶); cell refinement: CrysAlis PRO; data reduction: CrysAlis RED (Oxford Diffraction, 2007 ▶); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: SHELXTL (Sheldrick, 2008 ▶); software used to prepare material for publication: SHELXTL. Crystal structure: contains datablocks global, I. DOI: 10.1107/S1600536811000353/ng5098sup1.cif Structure factors: contains datablocks I. DOI: 10.1107/S1600536811000353/ng5098Isup2.hkl Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C15H12BrNO2F(000) = 1280
Mr = 318.17Dx = 1.635 Mg m3
Monoclinic, C2/cCu Kα radiation, λ = 1.54178 Å
Hall symbol: -C 2ycCell parameters from 3510 reflections
a = 26.3402 (13) Åθ = 4.7–74.0°
b = 3.8906 (2) ŵ = 4.31 mm1
c = 27.5826 (17) ÅT = 123 K
β = 113.892 (5)°Needle, colorless
V = 2584.4 (2) Å30.49 × 0.21 × 0.16 mm
Z = 8
Oxford Diffraction Xcalibur Ruby Gemini diffractometer2556 independent reflections
Radiation source: Enhance (Cu) X-ray Source2431 reflections with I > 2σ(I)
graphiteRint = 0.014
Detector resolution: 10.5081 pixels mm-1θmax = 74.1°, θmin = 6.0°
ω scansh = −29→32
Absorption correction: multi-scan (CrysAlis RED; Oxford Diffraction, 2007)k = −4→2
Tmin = 0.535, Tmax = 1.000l = −34→33
3978 measured reflections
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.040Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.115H-atom parameters constrained
S = 1.08w = 1/[σ2(Fo2) + (0.0704P)2 + 6.6225P] where P = (Fo2 + 2Fc2)/3
2556 reflections(Δ/σ)max < 0.001
173 parametersΔρmax = 0.85 e Å3
0 restraintsΔρmin = −0.64 e Å3
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
Br10.046034 (12)0.06121 (9)0.063358 (11)0.03852 (15)
O10.36895 (11)0.4707 (8)0.17800 (10)0.0507 (6)
O20.04309 (8)0.3262 (7)0.16281 (8)0.0431 (5)
N10.30803 (11)0.0395 (8)0.05431 (11)0.0410 (6)
C10.34866 (11)0.1894 (9)0.09571 (12)0.0359 (6)
C20.40303 (12)0.2175 (8)0.10013 (13)0.0382 (6)
H2A0.43080.32510.13000.046*
C30.41559 (13)0.0837 (9)0.05953 (15)0.0441 (8)
H3A0.45230.09560.06140.053*
C40.37382 (15)−0.0664 (9)0.01663 (15)0.0451 (8)
H4A0.3812−0.1569−0.01190.054*
C50.32078 (15)−0.0833 (9)0.01567 (14)0.0442 (8)
H5A0.2922−0.1875−0.01400.053*
C60.33420 (13)0.3330 (10)0.13914 (12)0.0420 (7)
C70.27542 (13)0.3026 (9)0.13151 (12)0.0410 (7)
H7A0.25030.17470.10230.049*
C80.25712 (14)0.4531 (9)0.16526 (13)0.0404 (7)
H8A0.28330.58570.19310.048*
C90.20072 (13)0.4324 (9)0.16324 (12)0.0389 (7)
C100.15685 (12)0.2790 (9)0.12093 (11)0.0359 (6)
H10A0.16280.19090.09150.043*
C110.10531 (11)0.2558 (7)0.12193 (11)0.0311 (6)
C120.09521 (12)0.3743 (8)0.16536 (11)0.0335 (6)
C130.13844 (13)0.5282 (9)0.20707 (13)0.0374 (7)
H13A0.13270.61350.23670.045*
C140.19004 (14)0.5571 (9)0.20544 (13)0.0395 (7)
H14A0.21920.66600.23410.047*
C150.03317 (15)0.4373 (11)0.20775 (14)0.0489 (9)
H15A−0.00490.37840.20240.073*
H15B0.03830.68680.21180.073*
H15C0.05940.32270.23980.073*
U11U22U33U12U13U23
Br10.0377 (2)0.0436 (2)0.0325 (2)−0.00132 (12)0.01247 (15)−0.00231 (12)
O10.0427 (13)0.0683 (16)0.0394 (13)−0.0095 (12)0.0149 (11)−0.0008 (11)
O20.0317 (10)0.0681 (15)0.0339 (10)0.0021 (11)0.0177 (8)−0.0024 (11)
N10.0317 (13)0.0494 (16)0.0400 (14)−0.0043 (11)0.0124 (11)0.0067 (12)
C10.0283 (13)0.0413 (16)0.0366 (14)−0.0025 (12)0.0116 (11)0.0114 (13)
C20.0291 (13)0.0392 (16)0.0450 (16)−0.0025 (12)0.0136 (12)0.0083 (13)
C30.0343 (16)0.0416 (19)0.060 (2)0.0050 (13)0.0231 (15)0.0099 (15)
C40.0501 (19)0.0388 (18)0.0502 (19)0.0078 (14)0.0241 (16)0.0077 (14)
C50.0418 (17)0.0439 (19)0.0430 (17)−0.0038 (13)0.0130 (14)0.0025 (14)
C60.0341 (14)0.0554 (19)0.0385 (16)0.0013 (14)0.0168 (13)0.0130 (15)
C70.0378 (15)0.0466 (18)0.0381 (15)−0.0029 (14)0.0149 (12)−0.0003 (14)
C80.0409 (16)0.0433 (18)0.0346 (15)−0.0030 (13)0.0130 (13)0.0018 (13)
C90.0340 (15)0.0511 (19)0.0322 (15)0.0061 (13)0.0141 (12)0.0104 (13)
C100.0342 (13)0.0466 (17)0.0288 (13)0.0082 (13)0.0147 (11)0.0069 (12)
C110.0319 (13)0.0315 (14)0.0289 (12)0.0025 (11)0.0113 (10)0.0037 (11)
C120.0301 (13)0.0391 (15)0.0325 (14)0.0051 (12)0.0140 (11)0.0040 (12)
C130.0385 (16)0.0416 (16)0.0326 (14)0.0069 (13)0.0149 (13)0.0001 (12)
C140.0354 (15)0.0464 (18)0.0322 (15)0.0004 (13)0.0092 (12)0.0028 (13)
C150.0409 (17)0.074 (3)0.0398 (17)0.0117 (16)0.0243 (15)0.0033 (16)
Br1—C111.892 (3)C7—C81.344 (5)
O1—C61.216 (4)C7—H7A0.9500
O2—C121.359 (3)C8—C91.466 (4)
O2—C151.433 (4)C8—H8A0.9500
N1—C51.329 (5)C9—C141.391 (5)
N1—C11.341 (4)C9—C101.400 (5)
C1—C21.391 (4)C10—C111.372 (4)
C1—C61.504 (5)C10—H10A0.9500
C2—C31.391 (5)C11—C121.406 (4)
C2—H2A0.9500C12—C131.385 (4)
C3—C41.377 (5)C13—C141.383 (5)
C3—H3A0.9500C13—H13A0.9500
C4—C51.388 (5)C14—H14A0.9500
C4—H4A0.9500C15—H15A0.9800
C5—H5A0.9500C15—H15B0.9800
C6—C71.480 (4)C15—H15C0.9800
C12—O2—C15116.6 (3)C9—C8—H8A116.8
C5—N1—C1117.7 (3)C14—C9—C10117.9 (3)
N1—C1—C2123.1 (3)C14—C9—C8119.6 (3)
N1—C1—C6117.9 (3)C10—C9—C8122.4 (3)
C2—C1—C6119.0 (3)C11—C10—C9120.0 (3)
C3—C2—C1118.2 (3)C11—C10—H10A120.0
C3—C2—H2A120.9C9—C10—H10A120.0
C1—C2—H2A120.9C10—C11—C12121.7 (3)
C4—C3—C2118.9 (3)C10—C11—Br1119.4 (2)
C4—C3—H3A120.6C12—C11—Br1118.9 (2)
C2—C3—H3A120.6O2—C12—C13125.2 (3)
C3—C4—C5118.9 (3)O2—C12—C11116.5 (3)
C3—C4—H4A120.5C13—C12—C11118.3 (3)
C5—C4—H4A120.5C14—C13—C12119.8 (3)
N1—C5—C4123.2 (3)C14—C13—H13A120.1
N1—C5—H5A118.4C12—C13—H13A120.1
C4—C5—H5A118.4C13—C14—C9122.2 (3)
O1—C6—C7122.1 (3)C13—C14—H14A118.9
O1—C6—C1121.5 (3)C9—C14—H14A118.9
C7—C6—C1116.4 (3)O2—C15—H15A109.5
C8—C7—C6121.0 (3)O2—C15—H15B109.5
C8—C7—H7A119.5H15A—C15—H15B109.5
C6—C7—H7A119.5O2—C15—H15C109.5
C7—C8—C9126.3 (3)H15A—C15—H15C109.5
C7—C8—H8A116.8H15B—C15—H15C109.5
C5—N1—C1—C2−0.8 (5)C7—C8—C9—C10−7.5 (5)
C5—N1—C1—C6179.2 (3)C14—C9—C10—C110.1 (5)
N1—C1—C2—C30.1 (5)C8—C9—C10—C11177.7 (3)
C6—C1—C2—C3−179.9 (3)C9—C10—C11—C12−1.8 (5)
C1—C2—C3—C40.8 (5)C9—C10—C11—Br1178.0 (2)
C2—C3—C4—C5−0.9 (5)C15—O2—C12—C13−1.6 (5)
C1—N1—C5—C40.7 (5)C15—O2—C12—C11178.1 (3)
C3—C4—C5—N10.1 (5)C10—C11—C12—O2−177.6 (3)
N1—C1—C6—O1179.6 (3)Br1—C11—C12—O22.7 (4)
C2—C1—C6—O1−0.4 (5)C10—C11—C12—C132.2 (5)
N1—C1—C6—C7−1.4 (4)Br1—C11—C12—C13−177.6 (2)
C2—C1—C6—C7178.6 (3)O2—C12—C13—C14178.9 (3)
O1—C6—C7—C85.8 (6)C11—C12—C13—C14−0.9 (5)
C1—C6—C7—C8−173.2 (3)C12—C13—C14—C9−0.8 (5)
C6—C7—C8—C9−177.7 (3)C10—C9—C14—C131.2 (5)
C7—C8—C9—C14170.1 (3)C8—C9—C14—C13−176.5 (3)
D—H···AD—HH···AD···AD—H···A
C3—H3A···Br1i0.953.043.870 (3)146
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯AD—HH⋯ADAD—H⋯A
C3—H3A⋯Br1i0.953.043.870 (3)146

Symmetry code: (i) .

  10 in total

Review 1.  Bioactivities of chalcones.

Authors:  J R Dimmock; D W Elias; M A Beazely; N M Kandepu
Journal:  Curr Med Chem       Date:  1999-12       Impact factor: 4.530

2.  Sulfonate chalcone as new class voltage-dependent K+ channel blocker.

Authors:  Oleg V Yarishkin; Hyung Won Ryu; Jae-Yong Park; Min Suk Yang; Seong-Geun Hong; Ki Hun Park
Journal:  Bioorg Med Chem Lett       Date:  2007-11-04       Impact factor: 2.823

3.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

Review 4.  Flavonoids: old and new aspects of a class of natural therapeutic drugs.

Authors:  G Di Carlo; N Mascolo; A A Izzo; F Capasso
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

5.  1-[3,5-Bis(4-fluoro-phen-yl)-4,5-dihydro-1H-pyrazol-1-yl]ethanone.

Authors:  Hoong-Kun Fun; Madhukar Hemamalini; S Samshuddin; B Narayana; H S Yathirajan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-02-10

6.  Methyl 4,6-bis-(4-fluoro-phen-yl)-2-oxo-cyclo-hex-3-ene-1-carboxyl-ate.

Authors:  Hoong-Kun Fun; Madhukar Hemamalini; S Samshuddin; B Narayana; H S Yathirajan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-03-17

7.  3,5-Bis(4-bromo-phen-yl)-1-phenyl-4,5-dihydro-1H-pyrazole.

Authors:  S Samshuddin; B Narayana; H S Yathirajan; A P Safwan; Edward R T Tiekink
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-05-08

8.  Synthesis and antihyperglycemic activity of chalcone based aryloxypropanolamines.

Authors:  M Satyanarayana; Priti Tiwari; Brajendra K Tripathi; A K Srivastava; Ram Pratap
Journal:  Bioorg Med Chem       Date:  2004-03-01       Impact factor: 3.641

9.  3,5-Bis(4-fluoro-phen-yl)-1-phenyl-4,5-dihydro-1H-pyrazole.

Authors:  Jerry P Jasinski; Curtis J Guild; S Samshuddin; B Narayana; H S Yathirajan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-07-07

10.  1-[3,5-Bis(4-chloro-phen-yl)-4,5-dihydro-1H-pyrazol-1-yl]ethanone.

Authors:  Jerry P Jasinski; Albert E Pek; S Samshuddin; B Narayana; H S Yathirajan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-07-07
  10 in total
  5 in total

1.  (2E)-3-(2-Anthracen-2-yl)-1-(2-hy-droxy-phen-yl)prop-2-en-1-one.

Authors:  Jerry P Jasinski; Ray J Butcher; V Musthafa Khaleel; B K Sarojini; H S Yathirajan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-03-05

2.  (2E)-3-(3,4-Dimeth-oxy-phen-yl)-1-(4-hy-droxy-phen-yl)prop-2-en-1-one.

Authors:  Jerry P Jasinski; Ray J Butcher; V Musthafa Khaleel; B K Sarojini; B Narayana
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-03-09

3.  (E)-3-(3,4-Dimeth-oxy-phen-yl)-1-(2-hy-droxy-phen-yl)prop-2-en-1-one.

Authors:  Jerry P Jasinski; Ray J Butcher; V Musthafa Khaleel; B K Sarojini; H S Yathirajan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-03-12

4.  (2E)-3-(4-Chloro-phen-yl)-1-(4-hy-droxy-phen-yl)prop-2-en-1-one.

Authors:  Jerry P Jasinski; Ray J Butcher; H S Yathirajan; B K Sarojini; V Musthafa Khaleel
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-03-02

5.  (2E)-3-[4-(Benz-yloxy)phen-yl]-1-(pyridin-3-yl)prop-2-en-1-one.

Authors:  Hoong-Kun Fun; Ching Kheng Quah; Prakash S Nayak; B Narayana; B K Sarojini
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-08-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.